Skip to search formSkip to main contentSkip to account menu

efonidipine

Known as: 3-Pyridinecarboxylic acid, 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(phenyl(phenylmethyl)amino)ethyl ester, P-oxide, monohydrochloride, 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylic acid, 2-(phenyl(phenylmethyl)amino) ethyl ester, P-oxide, hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efonidipine is a dual blocker of T-type and L-type calcium channels with 1, 4-dihydropyridine structure attached to a phosphonate… 
Review
2015
Review
2015
Background : According to the data provided by the Brazilian Nephrology Society, between the years 2000 and 2011 the number of… 
2012
2012
Objectives: Blockade of the T-type calcium channel (TCC), which is expressed in the renal efferent arterioles of the… 
2012
2012
Background : Hypertension is treated with both lifestyle modification and pharmacotherapy. The Seventh Report of the Joint… 
2010
2010
Purpose : Efonidipine, which inhibits both T- and L-type calcium channels, has been shown to be effective in reducing proteinuria… 
2009
2009
The extent of interaction between calcium channel antagonists and grapefruit juice varies widely among drugs. Coadministration of… 
2006
2006
To compare the antianginal eŠects of 1,4-dihydropyridine-type calcium-channel blockers, we evaluated the eŠects of benidipine…